Moderna

Markets

Moderna and Pfizer with 5.5% interest and 50% protection – columns

Moderna and Pfizer with 5.5% interest and 50% protection In the case of bonds and certificates whose potential returns depend…

Read More »
Latest

BioNTech, CureVac, Moderna: mRNA technology – potential to revolutionize medicine – Commerzbank column

The new “mRNA vaccines” are not only considered a major milestone in the fight against the corona pandemic – the…

Read More »
Latest

Moderna share: is the second attempt to turn the trend coming? – Chart analysis

The Moderna share fell on the NASDAQ on Friday by more than 2 percent to $ 112.75, while the share…

Read More »
Latest

Moderna share: Liberation beckons for the vaccine title – chart analysis

A quick technical look at the Moderna share, which yesterday showed light and shadow on the NASDAQ. At the end…

Read More »
Latest

In the morning: Moderna, BMW, VW and Tiffany in focus – Nord LB column

China’s service industry grew more slowly in December. According to a survey by Caixin / Markit, the Purchasing Managers’ Index…

Read More »
Latest

Moderna share and the COVID-19 vaccine: Today everything will be decided

A look at the current share prices for the Moderna share on the European trading venues shows: Investors seem confident…

Read More »
Latest

Moderna share has chances to reverse the trend: These brands are decisive – chart analysis

After the recent significant losses in the price of COVID-19 vaccine stocks such as the Moderna share, possible upward trend…

Read More »
Latest

In focus – BioNTech, CureVac, Moderna & Co .: SARS-CoV-2 vaccines – DWS column

The start of vaccinations against the SARS-CoV-2 virus is within reach. However, people in Germany are still reluctant when it…

Read More »
Latest

In the morning: Moderna, Dermapharm, Grand City Properties and Vodafone in focus – Nord LB column

The Japanese economy was on a recovery course in Q3. GDP rose faster than expected by 21.4%. Growth was driven…

Read More »
Latest

Moderna share: is the BioNTech picture repeated?

After the BioNTech share, the Moderna share could next move into the spotlight when it comes to COVID-19 vaccines: The…

Read More »
Back to top button
Close
Close